Industry News

Industry News

Mindfulness-Based Stress Reduction Benefits Breast Cancer Survivors

Jan 04, 2012

Women recently diagnosed with breast cancer have higher survival rates than those diagnosed in previous decades, according to the American Cancer Society. However, survivors continue to face health challenges after their treatments end. Previous research reports as many as 50 percent of breast cancer survivors are depressed... Read More

Progression-Free Survival Of Patients With Advanced Ovarian Cancer Extended By Targeted Therapy

Jan 04, 2012

Targeted drugs, which block or disrupt particular molecules involved in the growth of tumors, have been shown to be effective treatments against many types of cancer. A new phase 3 clinical trial conducted by the Gynecologic Oncology Group (GOG) showed that a targeted therapy called bevacizumab (Avastin) effectively delayed the progression of advanced ovarian cancer... Read More

Two Recent Studies Distinguish Kidney Cancer Subtypes And Provide Promising New Drug Targets

Jan 03, 2012

Two recent studies by Van Andel Research Institute scientists are providing a foundation for a more complete understanding of distinct kidney cancer subtypes, which could pave the way for better treatments. In a study published in Cancer Cell led by Kyle Furge, Ph.D. and Aikseng Ooi, Ph.D... Read More

Mechanism Explains How Hepatitis C Virus Survives In The Liver And How A New Antiviral Works

Jan 03, 2012

Viral diseases are still one of the biggest challenges to medical science. Thanks to thousands of years of co-evolution with humans, their ability to harness the biology of their human hosts to survive and thrive makes them very difficult to target with medical treatment... Read More

Transcriptional Elongation Control Takes On New Dimensions As Stowers Researchers Find Gene Class-Specific Elongation Factors

Jan 03, 2012

Life is complicated enough, so you can forgive the pioneers of DNA biology for glossing over transcriptional elongation control by RNA polymerase II, the quick and seemingly bulletproof penultimate step in the process that copies the information encoded in our DNA into protein-making instructions carried by messenger RNA. In a new report appearing in the Dec... Read More

Fish Oil May Hold Key To Leukemia Cure

Jan 03, 2012

A compound produced from fish oil that appears to target leukemia stem cells could lead to a cure for the disease, according to Penn State researchers... Read More

Gene Fusion In Lung Cancer Afflicting Never-Smokers May Be Target For Therapy

Jan 03, 2012

Smoking is a well-known risk factor for lung cancer, but nearly 25% of all lung cancer patients have never smoked. In a study published online in Genome Research (http://www.genome.org), researchers have identified a previously unknown gene fusion event that could explain a significant proportion of lung cancer cases in never-smokers, and might serve as a target for new therapies... Read More

Previously Unconnected Molecular Networks Conspire To Promote Cancer

Jan 03, 2012

An inflammation-promoting protein triggers deactivation of a tumor-suppressor that usually blocks cancer formation via the NOTCH signaling pathway, a team of researchers led by scientists at The University of Texas MD Anderson Cancer Center reports today in Molecular Cell... Read More

Enzyme That Flips Switch On Cells' Sugar Cravings Could Be Anti-Cancer Target

Jan 03, 2012

Cancer cells tend to take up more glucose than healthy cells, and researchers are increasingly interested in exploiting this tendency with drugs that target cancer cells' altered metabolism. Cancer cells' sugar cravings arise partly because they turn off their mitochondria, power sources that burn glucose efficiently, in favor of a more inefficient mode of using glucose... Read More

Autologous Stem Cell Transplantation Does Not Improve Overall Survival In Patients With Follicular Lymphoma

Jan 02, 2012

High-dose chemotherapy and autologous stem cell transplantation (HDC-ASCT), for previously untreated patients with advanced follicular lymphoma (FL) does not improve overall survival compared with conventional-dose chemotherapy alone, according to an online study published December 21 in the Journal of the National Cancer Institute... Read More

Previous Page   Next Page